Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map

Claudia C Dobler, Magdoleen H Farah, Allison S Morrow, Mouaz Alsawas, Raed Benkhadra, Bashar Hasan, Larry J Prokop, Zhen Wang, M Hassan Murad

Research output: Contribution to journalArticleResearchpeer-review

2 Downloads (Pure)

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease, usually caused by tobacco smoking, but other important risk factors include exposures to combustion products of biomass fuels and environmental pollution. The introduction of several new (combination) inhaler therapies, increasing uncertainty about the role of inhaled corticosteroids and a rapid proliferation of the literature on management of stable COPD in general, call for novel ways of evidence synthesis in this area. A systematic review and evidence map can provide the basis for shared decision-making tools and help to establish a future research agenda.

METHODS AND ANALYSIS: This systematic review will follow an umbrella systematic review design (also called overview of reviews). We plan to conduct a comprehensive literature search of Ovid MEDLINE (including epub ahead of print, in process and other non-indexed citations), Ovid Embase, Ovid Cochrane Database of Systematic Reviews and Scopus from database inception to the present. We will include systematic reviews that assessed the effectiveness of any pharmacological or non-pharmacological intervention on one or more patient-important outcomes and/or lung function in patients with stable COPD. For every intervention/outcome pair, one systematic review will be included. An a priori protocol will guide, which systematic reviews will be chosen, how their credibility will be evaluated, and how the quality of the body of evidence will be rated. Data will be synthesised into an evidence map that will present a matrix that depicts each available treatment for stable COPD with a quantitative estimate on symptoms/outcomes from the patient perspective, along with an indication of the size and certainty in the evidence.

ETHICS AND DISSEMINATION: Approval by a research ethics committee is not required since the review will only include published data. The systematic review will be published in a peer-reviewed journal.

PROSPERO REGISTRATION NUMBER: CRD42018095079.

Original languageEnglish
Article numbere027935
Pages (from-to)e027935
JournalBMJ Open
Volume9
Issue number5
DOIs
Publication statusPublished - 5 May 2019
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Databases
Environmental Pollution
Nebulizers and Vaporizers
Research Ethics Committees
Therapeutics
MEDLINE
Biomass
Lung Diseases
Uncertainty
Decision Making
Adrenal Cortex Hormones
Smoking
Pharmacology
Lung

Cite this

Dobler, C. C., Farah, M. H., Morrow, A. S., Alsawas, M., Benkhadra, R., Hasan, B., ... Murad, M. H. (2019). Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map. BMJ Open, 9(5), e027935. [e027935]. https://doi.org/10.1136/bmjopen-2018-027935
Dobler, Claudia C ; Farah, Magdoleen H ; Morrow, Allison S ; Alsawas, Mouaz ; Benkhadra, Raed ; Hasan, Bashar ; Prokop, Larry J ; Wang, Zhen ; Murad, M Hassan. / Treatment of stable chronic obstructive pulmonary disease : protocol for a systematic review and evidence map. In: BMJ Open. 2019 ; Vol. 9, No. 5. pp. e027935.
@article{aa7f2ac845174bc9b23e296f805f0c01,
title = "Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map",
abstract = "INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease, usually caused by tobacco smoking, but other important risk factors include exposures to combustion products of biomass fuels and environmental pollution. The introduction of several new (combination) inhaler therapies, increasing uncertainty about the role of inhaled corticosteroids and a rapid proliferation of the literature on management of stable COPD in general, call for novel ways of evidence synthesis in this area. A systematic review and evidence map can provide the basis for shared decision-making tools and help to establish a future research agenda.METHODS AND ANALYSIS: This systematic review will follow an umbrella systematic review design (also called overview of reviews). We plan to conduct a comprehensive literature search of Ovid MEDLINE (including epub ahead of print, in process and other non-indexed citations), Ovid Embase, Ovid Cochrane Database of Systematic Reviews and Scopus from database inception to the present. We will include systematic reviews that assessed the effectiveness of any pharmacological or non-pharmacological intervention on one or more patient-important outcomes and/or lung function in patients with stable COPD. For every intervention/outcome pair, one systematic review will be included. An a priori protocol will guide, which systematic reviews will be chosen, how their credibility will be evaluated, and how the quality of the body of evidence will be rated. Data will be synthesised into an evidence map that will present a matrix that depicts each available treatment for stable COPD with a quantitative estimate on symptoms/outcomes from the patient perspective, along with an indication of the size and certainty in the evidence.ETHICS AND DISSEMINATION: Approval by a research ethics committee is not required since the review will only include published data. The systematic review will be published in a peer-reviewed journal.PROSPERO REGISTRATION NUMBER: CRD42018095079.",
author = "Dobler, {Claudia C} and Farah, {Magdoleen H} and Morrow, {Allison S} and Mouaz Alsawas and Raed Benkhadra and Bashar Hasan and Prokop, {Larry J} and Zhen Wang and Murad, {M Hassan}",
note = "{\circledC} Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2019",
month = "5",
day = "5",
doi = "10.1136/bmjopen-2018-027935",
language = "English",
volume = "9",
pages = "e027935",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "5",

}

Dobler, CC, Farah, MH, Morrow, AS, Alsawas, M, Benkhadra, R, Hasan, B, Prokop, LJ, Wang, Z & Murad, MH 2019, 'Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map' BMJ Open, vol. 9, no. 5, e027935, pp. e027935. https://doi.org/10.1136/bmjopen-2018-027935

Treatment of stable chronic obstructive pulmonary disease : protocol for a systematic review and evidence map. / Dobler, Claudia C; Farah, Magdoleen H; Morrow, Allison S; Alsawas, Mouaz; Benkhadra, Raed; Hasan, Bashar; Prokop, Larry J; Wang, Zhen; Murad, M Hassan.

In: BMJ Open, Vol. 9, No. 5, e027935, 05.05.2019, p. e027935.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Treatment of stable chronic obstructive pulmonary disease

T2 - protocol for a systematic review and evidence map

AU - Dobler, Claudia C

AU - Farah, Magdoleen H

AU - Morrow, Allison S

AU - Alsawas, Mouaz

AU - Benkhadra, Raed

AU - Hasan, Bashar

AU - Prokop, Larry J

AU - Wang, Zhen

AU - Murad, M Hassan

N1 - © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2019/5/5

Y1 - 2019/5/5

N2 - INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease, usually caused by tobacco smoking, but other important risk factors include exposures to combustion products of biomass fuels and environmental pollution. The introduction of several new (combination) inhaler therapies, increasing uncertainty about the role of inhaled corticosteroids and a rapid proliferation of the literature on management of stable COPD in general, call for novel ways of evidence synthesis in this area. A systematic review and evidence map can provide the basis for shared decision-making tools and help to establish a future research agenda.METHODS AND ANALYSIS: This systematic review will follow an umbrella systematic review design (also called overview of reviews). We plan to conduct a comprehensive literature search of Ovid MEDLINE (including epub ahead of print, in process and other non-indexed citations), Ovid Embase, Ovid Cochrane Database of Systematic Reviews and Scopus from database inception to the present. We will include systematic reviews that assessed the effectiveness of any pharmacological or non-pharmacological intervention on one or more patient-important outcomes and/or lung function in patients with stable COPD. For every intervention/outcome pair, one systematic review will be included. An a priori protocol will guide, which systematic reviews will be chosen, how their credibility will be evaluated, and how the quality of the body of evidence will be rated. Data will be synthesised into an evidence map that will present a matrix that depicts each available treatment for stable COPD with a quantitative estimate on symptoms/outcomes from the patient perspective, along with an indication of the size and certainty in the evidence.ETHICS AND DISSEMINATION: Approval by a research ethics committee is not required since the review will only include published data. The systematic review will be published in a peer-reviewed journal.PROSPERO REGISTRATION NUMBER: CRD42018095079.

AB - INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease, usually caused by tobacco smoking, but other important risk factors include exposures to combustion products of biomass fuels and environmental pollution. The introduction of several new (combination) inhaler therapies, increasing uncertainty about the role of inhaled corticosteroids and a rapid proliferation of the literature on management of stable COPD in general, call for novel ways of evidence synthesis in this area. A systematic review and evidence map can provide the basis for shared decision-making tools and help to establish a future research agenda.METHODS AND ANALYSIS: This systematic review will follow an umbrella systematic review design (also called overview of reviews). We plan to conduct a comprehensive literature search of Ovid MEDLINE (including epub ahead of print, in process and other non-indexed citations), Ovid Embase, Ovid Cochrane Database of Systematic Reviews and Scopus from database inception to the present. We will include systematic reviews that assessed the effectiveness of any pharmacological or non-pharmacological intervention on one or more patient-important outcomes and/or lung function in patients with stable COPD. For every intervention/outcome pair, one systematic review will be included. An a priori protocol will guide, which systematic reviews will be chosen, how their credibility will be evaluated, and how the quality of the body of evidence will be rated. Data will be synthesised into an evidence map that will present a matrix that depicts each available treatment for stable COPD with a quantitative estimate on symptoms/outcomes from the patient perspective, along with an indication of the size and certainty in the evidence.ETHICS AND DISSEMINATION: Approval by a research ethics committee is not required since the review will only include published data. The systematic review will be published in a peer-reviewed journal.PROSPERO REGISTRATION NUMBER: CRD42018095079.

UR - http://www.scopus.com/inward/record.url?scp=85065392272&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-027935

DO - 10.1136/bmjopen-2018-027935

M3 - Article

VL - 9

SP - e027935

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 5

M1 - e027935

ER -